Trial NCT00036855

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-01871
Secondary IDs: ADVL0013 CDR0000069331 U01CA097452

Last trial update was posted on 2013-01-17

MeSH Interventions

Antibodies, Monoclonal Rituximab

MeSH Conditions

Lymphoma Lymphoma, Non-Hodgkin Lymphoproliferative Disorders Precursor Cell Lymphoblastic Leukemia-Lymphoma Recurrence

Other Conditions

AIDS-related Peripheral/Systemic Lymphoma AIDS-related Primary CNS Lymphoma Post-transplant Lymphoproliferative Disorder Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma

Stopping Reasons

Administratively complete.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID